Home Cart Sign in  
Chemical Structure| 1082744-20-4 Chemical Structure| 1082744-20-4

Structure of Edelinontrine
CAS No.: 1082744-20-4

Chemical Structure| 1082744-20-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

PF-04447943 is a potent, selective brain penetrant PDE9 inhibitor (Ki of 2.8, 4.5 and 18 nM) for human, rhesus and rat recombinant PDE9 respectively and high selectivity for PDE9 versus PDEs1-8 and 10-11.

Synonyms: PF-04447943

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Edelinontrine

CAS No. :1082744-20-4
Formula : C20H25N7O2
M.W : 395.46
SMILES Code : O=C1C2=C(N(C3CCOCC3)N=C2)N=C([C@@H]4CN(CC5=NC=CC=N5)C[C@H]4C)N1
Synonyms :
PF-04447943
MDL No. :MFCD22665724

Safety of Edelinontrine

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H317
Precautionary Statements:P280-P305+P351+P338

Isoform Comparison

Biological Activity

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Male C57BL/6 mice Aged mouse model Intraperitoneal injection 1 mg/kg/day Once daily for 10 days To evaluate the effects of PF-04447943 on left ventricular function and pulmonary vascular resistance in aged mice. Results showed that PF-04447943 treatment significantly reduced pulmonary vascular resistance in aged mice but had no significant effect on left ventricular systolic or diastolic function. PMC11335997
Female C57BL/6 mice DSS-induced colitis model Oral gavage 3 mg/kg, 10 mg/kg, 30 mg/kg Once daily for 7 days To evaluate the protective effect of PF-04447943 on DSS-induced colitis, results showed that PF-04447943 attenuated colitis by suppressing oxidative stress and inflammation as well as reversing the Treg/Th17 cells imbalance. PMC8098793
Rats BACHD transgenic rats (TG5) Subcutaneous injection 3.2 mg/kg Single administration, recording lasted 30-180 minutes To assess the impact of PF-04447943 on corticostriatal transmission in WT and TG5 rats. Results showed that PF-04447943 significantly decreased the onset latency of cortically-evoked spikes in MSNs recorded in WT and TG5 rats and reversed deficits in spike probability observed in TG5 rats. PMC7283904

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.53mL

0.51mL

0.25mL

12.64mL

2.53mL

1.26mL

25.29mL

5.06mL

2.53mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories